Articles By David Liew
Artificial intelligence brings clarity to early bony changes in inflammatory arthritis
By David Liew
16 June 2021
Subtle early bony changes in inflammatory arthritis can be hard even for experienced rheumatologists to interpret, even though they have traditionally been considered to become disease-defining as they progress.
Read Article
Israel provides COVID vaccine answers for rheumatic disease patients
By David Liew
07 June 2021
The question as to how autoimmune rheumatic disease patients fare with the COVID vaccine is one being asked in rheumatologists’ offices everywhere this year, and at the EULAR 2021 Virtual Congress, data presented from Israel, one of the first countries to vaccinate on a br
Read Article
Warfarin and End-Stage Osteoarthritis
By David Liew
18 November 2020
Dr. David Liew discusses abstract #0934 - "Warfarin Use and Risk of Knee and Hip Replacements" - presented at the 2020 ACR annual meeting.
Read Article
Erosions on X-ray: can we delegate this to the computers?
By David Liew
12 November 2020
The prospect of automating hand x-ray scoring reliably has always been an enticing one, and data presented at the American College of Rheumatology (ACR) Convergence 2020 suggest this might be in reach in the near future – opening up the prospect of automatic x-ray scoring
Read Article
Building an ACR Annual Meeting for the Whole World
By David Liew
06 November 2020
For many rheumatologists around the world, coming to America was a pilgrimage of sorts. A long journey and an expensive exercise but a worthy one – a fundamentally human exchange of ideas, where the person next to you could be from Arkansas, Alberta, or Amsterdam, but equally from Argentina, Algeria, Azerbaijan, or even Australia. So how (dare I say, on earth) do we translate that to our electronic screens?
Read Article
Serum calprotectin: a better biomarker in ANCA-associated vasculitis?
By David Liew
10 June 2020
Flares in ANCA-associated vasculitis are difficult to predict, but serum calprotectin may help predict relapse and renal failure, according to data presented at the EULAR 2020 virtual meeting this week.
Read Article
Rheumatic Immune-Related Adverse Events: Not Just Another IrAE
By David Liew
27 November 2019
Rheumatic immune-related adverse events can start at almost any time after the commencement after immune checkpoint inhibitor immunotherapy for cancer, and are liable to persist long after the immunotherapy has ceased, according to data presented at ACR 2019 in Atlanta, Georgia.
Read Article
Hepatitis C-Related Cryoglobulinemic Vasculitis
By David Liew
19 November 2019
Flares of vasculitis can still be a problem after hepatitis C-related cryoglobulinemic vasculitis patients are cured of their hepatitis C by direct-acting antivirals, as demonstrated by data from four registries presented at ACR 2019 in Atlanta, Georgia.
Read Article
Ultrasound Reveals Which Anti-CCP Positive Patients Progress to Arthritis
By David Liew
02 July 2019
Editor's note: July 1 - 5, RheumNow is running the best of the EULAR 2019 meeting. Power Doppler signal on baseline ultrasound exam may well help stratify anti-CCP positive patients with musculoskeletal symptoms but no clinical synovitis, according to data from the Leeds Institute of Rhe
Read Article
Understanding Non-arthritic Rheumatic iRAEs
By David Liew
17 June 2019
A better understanding of rheumatic immune-related adverse event phenotypes beyond inflammatory arthritis has been furthered by work from three abstracts presented at EULAR 2019 in Madrid.
Read Article